semaglutide and cardiovascular disease Recent study at UC Irvine found that medication may benefit 93 million U.S. adults semaglutide death 🔴Cardiovascular outcomes with

Use a clean needle and syringe for each shot

Glucagon-like peptide-1 receptor agonists in peri-operative care Dispelling myths and unveiling insights with essential considerations for anaesthesiologists Larissa Paggers Dieter Mesotten Hendrik Stragier With the growing use of glucagon-like-peptide-1 (GLP-1) receptor (GLP-1R) agonists as anti-obesity medication it is becoming increasingly important to examine its consequences in the peri-operative period

These include access to GLP-1 agonist medications like Ozempic and Mounjaro, as well as nutritionist-recommended supplements to help optimise weight loss

Document sleep, appetite, and GI notes alongside any GLP-1 peptide education log

It is for educational purposes only and is not medical advice, a recommendation, or a substitute for professional healthcare guidance